File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.semcancer.2006.03.003
- Scopus: eid_2-s2.0-33646903670
- PMID: 16697216
- WOS: WOS:000238730800005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways
Title | Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways |
---|---|
Authors | |
Keywords | 14-3-3 Apoptosis Survival signaling BAD JNK |
Issue Date | 2006 |
Publisher | Academic Press. The Journal's web site is located at http://www.elsevier.com/locate/semcancer |
Citation | Seminars in Cancer Biology, 2006, v. 16 n. 3, p. 193-202 How to Cite? |
Abstract | The serine/threonine binding protein, 14-3-3, possesses a diverse array of client proteins. It is involved in the regulation of apoptosis through multiple interactions with proteins of the core mitochondrial machinery, pro-apoptotic transcription factors, and their upstream signaling pathways. 14-3-3 coordinates with survival kinases to inhibit multiple pro-apoptotic molecules. One prominent mechanism for the suppression of apoptosis is through 14-3-3-mediated sequestration of pro-apoptotic client proteins. On the other hand, cellular stresses appear to signal through the inhibition of 14-3-3 function to exert their pro-apoptotic effect. Global inhibition of 14-3-3/client protein interaction induces apoptosis, and stands as an attractive intervention in diseases involving overactive survival signaling pathways. Because dysregulation of 14-3-3 has been associated with poor survival of cancer patients, targeting 14-3-3 may provide a novel therapeutic approach for the treatment of cancer. © 2006 Elsevier Ltd. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/219910 |
ISSN | 2023 Impact Factor: 12.1 2023 SCImago Journal Rankings: 3.297 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Porter, GW | - |
dc.contributor.author | Khuri, FR | - |
dc.contributor.author | Fu, H | - |
dc.date.accessioned | 2015-09-30T08:43:26Z | - |
dc.date.available | 2015-09-30T08:43:26Z | - |
dc.date.issued | 2006 | - |
dc.identifier.citation | Seminars in Cancer Biology, 2006, v. 16 n. 3, p. 193-202 | - |
dc.identifier.issn | 1044-579X | - |
dc.identifier.uri | http://hdl.handle.net/10722/219910 | - |
dc.description.abstract | The serine/threonine binding protein, 14-3-3, possesses a diverse array of client proteins. It is involved in the regulation of apoptosis through multiple interactions with proteins of the core mitochondrial machinery, pro-apoptotic transcription factors, and their upstream signaling pathways. 14-3-3 coordinates with survival kinases to inhibit multiple pro-apoptotic molecules. One prominent mechanism for the suppression of apoptosis is through 14-3-3-mediated sequestration of pro-apoptotic client proteins. On the other hand, cellular stresses appear to signal through the inhibition of 14-3-3 function to exert their pro-apoptotic effect. Global inhibition of 14-3-3/client protein interaction induces apoptosis, and stands as an attractive intervention in diseases involving overactive survival signaling pathways. Because dysregulation of 14-3-3 has been associated with poor survival of cancer patients, targeting 14-3-3 may provide a novel therapeutic approach for the treatment of cancer. © 2006 Elsevier Ltd. All rights reserved. | - |
dc.language | eng | - |
dc.publisher | Academic Press. The Journal's web site is located at http://www.elsevier.com/locate/semcancer | - |
dc.relation.ispartof | Seminars in Cancer Biology | - |
dc.subject | 14-3-3 | - |
dc.subject | Apoptosis | - |
dc.subject | Survival signaling | - |
dc.subject | BAD | - |
dc.subject | JNK | - |
dc.title | Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways | - |
dc.type | Article | - |
dc.identifier.email | Porter, GW: porterg@hku.hk | - |
dc.identifier.authority | Porter, GW=rp02099 | - |
dc.identifier.doi | 10.1016/j.semcancer.2006.03.003 | - |
dc.identifier.pmid | 16697216 | - |
dc.identifier.scopus | eid_2-s2.0-33646903670 | - |
dc.identifier.volume | 16 | - |
dc.identifier.issue | 3 | - |
dc.identifier.spage | 193 | - |
dc.identifier.epage | 202 | - |
dc.identifier.isi | WOS:000238730800005 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 1044-579X | - |